サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1762491

パージェタ (Perjeta) の世界市場：市場規模・シェア・動向、業界分析 (種類別・製品別・適応症別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Perjeta Market Size, Share, & Industry Analysis Report: By Type, By Product (Monoclonal Antibody and Generic Drug), By Indication, By Distribution Channel, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
パージェタ (Perjeta) の世界市場：市場規模・シェア・動向、業界分析 (種類別・製品別・適応症別・流通チャネル別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、パージェタ (Perjeta) の市場規模は2034年までに71億3,000万米ドルに達する見込みです。同レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

パージェタは、がん細胞のシグナル伝達経路を破壊するHER2標的モノクローナル抗体療法であり、超個別化医療へのシフトが進む中、腫瘍学市場で勢いを増し続けています。この動向は、個々の腫瘍プロファイルに合わせた生物学的製剤の使用を強調しており、パージェタはHER2陽性の治療レジメンにおいて重要な要素となっています。パージェタが提供する高精度ターゲティングは、全身毒性を最小限に抑えながら治療効果を向上させ、患者ごとにカスタマイズされたがん治療を目指す広範な動きと一致しています。治療パラダイムの進化に伴い、医療提供者は、分子的精密性と測定可能な臨床転帰を提供する治療をますます優先するようになっています。

治療効果を最適化するための併用療法の統合が進んでいることも、業界の成長機会に寄与しています。トラスツズマブおよび化学療法と並行して投与されることが一般的なパージェタは、相乗効果を示し、包括的なHER2陽性乳がん管理の要としての採用を後押ししています。この併用戦略は、HER2受容体の遮断を改善し、病勢進行のリスクを低減し、患者の生存率向上に寄与します。臨床における多剤併用療法の継続的な検討は、強固で持続的な奏効をもたらす先進的治療に対する需要を浮き彫りにしており、パージェタが現代の腫瘍学的治療において重要であることを強調しています。

パージェタ市場：分析概要

製品別では、HER2陽性乳がん治療におけるモノクローナル抗体の正確なターゲティングメカニズムと実証された臨床効果により、モノクローナル抗体セグメントが2024年に大きな売上シェアを占めました。

販売チャネル別では、デジタル医療ソリューションに対する消費者の嗜好の進化と、専門的な医薬品への便利なアクセスに対する需要の高まりにより、オンライン薬局分野が予測期間中に最も速い成長率を記録すると予測されています。

2024年、北米は、洗練された医療システム、強い疾患認知度、高度ながん治療薬の幅広い入手可能性などに支えられ、業界の主導的地位を占めています。

アジア太平洋のパージェタ市場は、健康意識の高まり、がん検出技術の進歩、がん治療施設への投資拡大などを背景に、予測期間中に最も急速なペースで拡大すると予想されます。

世界の主要企業としては、F. Hoffmann-La Roche Ltd.、Biocon、Samsung Bioepis、Pfizer Inc.、Genentech, Inc.、Dr. Reddy's Laboratories Ltd.、CELLTRION INC.などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界のパージェタ市場の洞察

  • 市場スナップショット
  • パージェタの市場力学
    • 促進要因と機会
      • 慢性疾患の有病率の上昇
      • 急速に増加する高齢者人口
    • 抑制要因と課題
      • 熟練労働者の不足
  • PESTLE分析
  • パージェタ市場の動向
  • バリューチェーン分析

第5章 世界のパージェタ市場：製品別

  • 主な分析結果
  • イントロダクション
  • モノクローナル抗体
  • ジェネリック医薬品

第6章 世界のパージェタ市場：適応症別

  • 主な分析結果
  • イントロダクション
  • 早期乳がん
  • 転移性乳がん

第7章 世界のパージェタ市場：流通チャネル別

  • 主な分析結果
  • イントロダクション
  • 病院薬局
  • 専門薬局
  • オンライン薬局

第8章 世界のパージェタ市場：地域別

  • 主な分析結果
  • イントロダクション
    • パージェタ市場の分析：地域別 (2020～2034年)
  • 北米
    • 北米：製品別（2020～2034年）
    • 北米：適応症別（2020～2034年）
    • 北米：流通チャネル別（2020～2034年）
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別（2020～2034年）
    • 欧州：適応症別（2020～2034年）
    • 欧州：流通チャネル別（2020～2034年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品別（2020～2034年）
    • アジア太平洋：適応症別（2020～2034年）
    • アジア太平洋：流通チャネル別（2020～2034年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：製品別（2020～2034年）
    • 中東・アフリカ：適応症別（2020～2034年）
    • 中東・アフリカ：流通チャネル別（2020～2034年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別（2020～2034年）
    • ラテンアメリカ：適応症別（2020～2034年）
    • ラテンアメリカ：流通チャネル別、2020年～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Biocon
  • Samsung Bioepis.
  • Pfizer Inc.
  • Genentech, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • CELLTRION INC.
図表

List of Tables:

  • Table 1 Global Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 2 Global Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 3 Global Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 4 North America: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 5 North America: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 6 North America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 7 U.S.: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 8 U.S.: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 9 U.S.: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 10 Canada: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 11 Canada: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 12 Canada: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 13 Europe: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 14 Europe: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 15 Europe: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 16 UK: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 17 UK: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 18 UK: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 19 France: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 20 France: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 21 France: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 22 Germany: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 23 Germany: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 24 Germany: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 25 Italy: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 26 Italy: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 27 Italy: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 28 Spain: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 29 Spain: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 30 Spain: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 31 Netherlands: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 32 Netherlands: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 33 Netherlands: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 34 Russia: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 35 Russia: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 36 Russia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 37 Rest of Europe: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 38 Rest of Europe: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 39 Rest of Europe: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 40 Asia Pacific: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 41 Asia Pacific: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 42 Asia Pacific: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 43 China: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 44 China: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 45 China: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 46 India: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 47 India: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 48 India: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 49 Malaysia: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 50 Malaysia: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 51 Malaysia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 52 Japan: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 53 Japan: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 54 Japan: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 55 Indonesia: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 56 Indonesia: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 57 Indonesia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 58 South Korea: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 59 South Korea: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 60 South Korea: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 61 Australia: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 62 Australia: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 63 Australia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 64 Rest of Asia Pacific: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 65 Rest of Asia Pacific: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 66 Rest of Asia Pacific: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 67 Middle East & Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 68 Middle East & Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 69 Middle East & Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 70 Saudi Arabia: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 71 Saudi Arabia: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 72 Saudi Arabia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 73 UAE: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 74 UAE: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 75 UAE: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 76 Israel: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 77 Israel: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 78 Israel: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 79 South Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 80 South Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 81 South Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 82 Rest of Middle East & Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 83 Rest of Middle East & Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 84 Rest of Middle East & Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 85 Latin America: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 86 Latin America: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 87 Latin America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 88 Mexico: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 89 Mexico: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 90 Mexico: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 91 Brazil: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 92 Brazil: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 93 Brazil: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 94 Argentina: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 95 Argentina: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 96 Argentina: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 97 Rest of Latin America: Perjeta Market, by Product, 2020-2034 (USD billion)
  • Table 98 Rest of Latin America: Perjeta Market, by Indication, 2020-2034 (USD billion)
  • Table 99 Rest of Latin America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Perjeta Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Perjeta Market, by Product, 2024 & 2034 (USD billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Perjeta Market, by Indication, 2024 & 2034 (USD billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Perjeta Market, by Distribution Channel, 2024 & 2034 (USD billion)
  • Figure 12. Global Perjeta Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 13. Strategic Analysis - Global Perjeta Market
目次
Product Code: PM5704

The perjeta market size is expected to reach USD 7.13 billion by 2034, according to a new study by Polaris Market Research. The report "Perjeta Market Share, Size, & Industry Analysis Report: By Type, By Product (Monoclonal Antibody and Generic Drug), By Indication, By Distribution Channel, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Perjeta is a HER2-targeted monoclonal antibody therapy that disrupts cancer cell signaling pathways, with a continuation to gain momentum in the oncology market amid a growing shift toward hyper personalized medicine. This trend highlights the use of biologic therapies tailored to individual tumor profiles, making Perjeta a critical component in HER2-positive treatment regimens. The precision targeting offered by Perjeta improves therapeutic efficacy while minimizing systemic toxicity, aligning with the broader movement toward customized, patient-specific cancer care. Healthcare providers are increasingly prioritizing therapies that offer molecular precision and measurable clinical outcomes as treatment paradigms evolve.

The increasing integration of combination therapies to optimize treatment effectiveness contributes to industry growth opportunities. Perjeta, commonly administered alongside trastuzumab and chemotherapy, has demonstrated synergistic benefits, driving its adoption as a cornerstone in comprehensive HER2-positive breast cancer management. This combination strategy improves the blockade of HER2 receptors and reduces disease progression risks, contributing to improved patient survival. The continued exploration of multi-agent regimens in clinical practice highlights the demand for advanced therapies that deliver robust, durable responses, reinforcing Perjeta's relevance in contemporary oncologic care.

Perjeta Market Report Highlights

In terms of product, the monoclonal antibodies segment accounted for a larger revenue share in 2024, owing to their precise targeting mechanism and demonstrated clinical effectiveness in HER2-positive breast cancer treatment.

Based on distribution channel, the online pharmacies segment is anticipated to register the fastest growth rate during the forecast period, driven by evolving consumer preferences toward digital healthcare solutions and the rising demand for convenient access to specialized medications.

In 2024, North America held the leading position in the industry, supported by its sophisticated healthcare systems, strong disease awareness, and broad availability of advanced cancer treatments.

The Asia Pacific Perjeta market is expected to expand at the most rapid pace during the forecast period, driven by increasing health consciousness, advancements in cancer detection technologies, and expanding investments in cancer care facilities.

A few global key market players include F. Hoffmann-La Roche Ltd; Biocon; Samsung Bioepis; Pfizer Inc.; Genentech, Inc.; Dr. Reddy's Laboratories Ltd.; and CELLTRION INC.

Polaris Market Research has segmented the Perjeta market report on the basis of type, application, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibody

Generic Drug

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Early Breast Cancer

Metastatic Breast Cancer

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacies

Specialty Pharmacies

Online Pharmacies

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Perjeta Market Insights

  • 4.1. Perjeta Market - Market Snapshot
  • 4.2. Perjeta Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Rapidly Growing Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Labors
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Perjeta Market Trends
  • 4.6. Value Chain Analysis

5. Global Perjeta Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Perjeta Market, by Product, 2020-2034 (USD billion)
  • 5.3. Monoclonal Antibody
    • 5.3.1. Global Perjeta Market, by Monoclonal Antibody, by Region, 2020-2034 (USD billion)
  • 5.4. Generic Drug
    • 5.4.1. Global Perjeta Market, by Generic Drug, by Region, 2020-2034 (USD billion)

6. Global Perjeta Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Perjeta Market, by Indication, 2020-2034 (USD billion)
  • 6.3. Early Breast Cancer
    • 6.3.1. Global Perjeta Market, by Early Breast Cancer, by Region, 2020-2034 (USD billion)
  • 6.4. Metastatic Breast Cancer
    • 6.4.1. Global Perjeta Market, by Metastatic Breast Cancer, by Region, 2020-2034 (USD billion)

7. Global Perjeta Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Perjeta Market, by Hospital Pharmacies, by Region, 2020-2034 (USD billion)
  • 7.4. Specialty Pharmacies
    • 7.4.1. Global Perjeta Market, by Specialty Pharmacies, by Region, 2020-2034 (USD billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Perjeta Market, by Online Pharmacies, by Region, 2020-2034 (USD billion)

8. Global Perjeta Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Perjeta Market Assessment, By Geography, 2020-2034 (USD billion)
  • 8.3. Perjeta Market - North America
    • 8.3.1. North America: Perjeta Market, by Product, 2020-2034 (USD billion)
    • 8.3.2. North America: Perjeta Market, by Indication, 2020-2034 (USD billion)
    • 8.3.3. North America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.3.4. Perjeta Market - U.S.
      • 8.3.4.1. U.S.: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.3.4.2. U.S.: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.3.4.3. U.S.: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.3.5. Perjeta Market - Canada
      • 8.3.5.1. Canada: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.3.5.2. Canada: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.3.5.3. Canada: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.4. Perjeta Market - Europe
    • 8.4.1. Europe: Perjeta Market, by Product, 2020-2034 (USD billion)
    • 8.4.2. Europe: Perjeta Market, by Indication, 2020-2034 (USD billion)
    • 8.4.3. Europe: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.4. Perjeta Market - UK
      • 8.4.4.1. UK: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.4.2. UK: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.4.3. UK: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.5. Perjeta Market - France
      • 8.4.5.1. France: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.5.2. France: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.5.3. France: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.6. Perjeta Market - Germany
      • 8.4.6.1. Germany: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.6.2. Germany: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.6.3. Germany: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.7. Perjeta Market - Italy
      • 8.4.7.1. Italy: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.7.2. Italy: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.7.3. Italy: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.8. Perjeta Market - Spain
      • 8.4.8.1. Spain: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.8.2. Spain: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.8.3. Spain: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.9. Perjeta Market - Netherlands
      • 8.4.9.1. Netherlands: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.9.2. Netherlands: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.9.3. Netherlands: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.10. Perjeta Market - Russia
      • 8.4.10.1. Russia: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.10.2. Russia: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.10.3. Russia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.4.11. Perjeta Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.4.11.2. Rest of Europe: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.4.11.3. Rest of Europe: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.5. Perjeta Market - Asia Pacific
    • 8.5.1. Asia Pacific: Perjeta Market, by Product, 2020-2034 (USD billion)
    • 8.5.2. Asia Pacific: Perjeta Market, by Indication, 2020-2034 (USD billion)
    • 8.5.3. Asia Pacific: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.4. Perjeta Market - China
      • 8.5.4.1. China: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.4.2. China: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.4.3. China: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.5. Perjeta Market - India
      • 8.5.5.1. India: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.5.2. India: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.5.3. India: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.6. Perjeta Market - Malaysia
      • 8.5.6.1. Malaysia: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.6.2. Malaysia: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.6.3. Malaysia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.7. Perjeta Market - Japan
      • 8.5.7.1. Japan: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.7.2. Japan: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.7.3. Japan: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.8. Perjeta Market - Indonesia
      • 8.5.8.1. Indonesia: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.8.2. Indonesia: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.8.3. Indonesia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.9. Perjeta Market - South Korea
      • 8.5.9.1. South Korea: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.9.2. South Korea: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.9.3. South Korea: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.10. Perjeta Market - Australia
      • 8.5.10.1. Australia: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.10.2. Australia: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.10.3. Australia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.5.11. Perjeta Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.6. Perjeta Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
    • 8.6.2. Middle East & Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
    • 8.6.3. Middle East & Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.6.4. Perjeta Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.6.4.2. Saudi Arabia: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.6.4.3. Saudi Arabia: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.6.5. Perjeta Market - UAE
      • 8.6.5.1. UAE: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.6.5.2. UAE: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.6.5.3. UAE: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.6.6. Perjeta Market - Israel
      • 8.6.6.1. Israel: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.6.6.2. Israel: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.6.6.3. Israel: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.6.7. Perjeta Market - South Africa
      • 8.6.7.1. South Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.6.7.2. South Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.6.7.3. South Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.6.8. Perjeta Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.7. Perjeta Market - Latin America
    • 8.7.1. Latin America: Perjeta Market, by Product, 2020-2034 (USD billion)
    • 8.7.2. Latin America: Perjeta Market, by Indication, 2020-2034 (USD billion)
    • 8.7.3. Latin America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.7.4. Perjeta Market - Mexico
      • 8.7.4.1. Mexico: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.7.4.2. Mexico: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.7.4.3. Mexico: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.7.5. Perjeta Market - Brazil
      • 8.7.5.1. Brazil: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.7.5.2. Brazil: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.7.5.3. Brazil: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.7.6. Perjeta Market - Argentina
      • 8.7.6.1. Argentina: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.7.6.2. Argentina: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.7.6.3. Argentina: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)
    • 8.7.7. Perjeta Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Perjeta Market, by Product, 2020-2034 (USD billion)
      • 8.7.7.2. Rest of Latin America: Perjeta Market, by Indication, 2020-2034 (USD billion)
      • 8.7.7.3. Rest of Latin America: Perjeta Market, by Distribution Channel, 2020-2034 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. F. Hoffmann-La Roche Ltd
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Biocon
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Samsung Bioepis.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Pfizer Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Genentech, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dr. Reddy's Laboratories Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. CELLTRION INC.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development